Michael W. Bonney - May 15, 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: Brett Budzinski, Attorney-in-Fact For: Michael W. Bonney
Stock symbol
ALNY
Transactions as of
May 15, 2025
Transactions value $
-$1,648,104
Form type
4
Date filed
5/19/2025, 04:17 PM
Previous filing
May 12, 2025
Next filing
Aug 19, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BONNEY MICHAEL W Director 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Michael W. Bonney 2025-05-19 0001219016

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $1.48M +11.3K +66.95% $131.21 28.1K May 15, 2025 Direct F1
transaction ALNY Common Stock Sale -$147K -549 -1.96% $267.14 27.5K May 15, 2025 Direct F1, F2
transaction ALNY Common Stock Sale -$196K -729 -2.65% $268.56 26.8K May 15, 2025 Direct F1, F3
transaction ALNY Common Stock Sale -$66.1K -245 -0.91% $269.79 26.5K May 15, 2025 Direct F1, F4
transaction ALNY Common Stock Sale -$117K -431 -1.62% $271.68 26.1K May 15, 2025 Direct F1, F5
transaction ALNY Common Stock Sale -$180K -660 -2.53% $273.16 25.4K May 15, 2025 Direct F1, F6
transaction ALNY Common Stock Sale -$241K -882 -3.47% $273.75 24.6K May 15, 2025 Direct F1, F7
transaction ALNY Common Stock Sale -$83K -301 -1.23% $275.63 24.3K May 15, 2025 Direct F1, F8
transaction ALNY Common Stock Sale -$350K -1.26K -5.21% $277.16 23K May 15, 2025 Direct F1, F9
transaction ALNY Common Stock Sale -$344K -1.24K -5.39% $278.01 21.8K May 15, 2025 Direct F1, F10
transaction ALNY Common Stock Sale -$121K -432 -1.99% $280.03 21.3K May 15, 2025 Direct F1, F11
transaction ALNY Common Stock Sale -$105K -372 -1.74% $281.10 21K May 15, 2025 Direct F1, F12
transaction ALNY Common Stock Sale -$226K -802 -3.83% $282.03 20.1K May 15, 2025 Direct F1, F13
transaction ALNY Common Stock Sale -$489K -1.73K -8.58% $282.81 18.4K May 15, 2025 Direct F1, F14
transaction ALNY Common Stock Sale -$459K -1.62K -8.78% $283.83 16.8K May 15, 2025 Direct F1, F15
holding ALNY Common Stock 4K May 15, 2025 by Trust F16

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -11.3K -100% $0.00 0 May 15, 2025 Common Stock 11.3K $131.21 Direct F1, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $266.87 to $267.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $268.28 to $269.16. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $269.53 to $269.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $271.44 to $272.10. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $272.60 to $273.59. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $273.61 to $274.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $275.11 to $276.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $276.55 to $277.45. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $277.77 to $278.43. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $279.26 to $280.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $280.38 to $281.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $281.39 to $282.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F14 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $282.40 to $283.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F15 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $283.54 to $284.22. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F16 The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee.
F17 The stock option was fully vested as of June 1, 2016.